Induction of prolonged survival of CD4⁺ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients
J. Clin. Invest. Joseph A. Kovacs, et al. 115:2139 doi:10.1172/JCI23196 [Go to this article.]

Table 3
Changes in naive and memory subsets of CD4 and CD8 cells in patients participating in a randomized trial of IL-2